[^1]
[^2]
[^3]
[^4]
| MCPH1 (Microcephalin) |
|---|
| Gene | [MCPH1](/genes/MCPH1) |
| UniProt | Q9BXM8 |
| PDB Structures | 3LNU, 3LNV |
| Molecular Weight | 93 kDa |
| Localization | Nucleus, centrosome |
| Protein Family | BRCT domain family |
Mcph1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
This page provides comprehensive information about this protein. See the content below for detailed information.
MCPH1 (also known as BRIT1) is a DNA damage response protein critical for proper brain development. Mutations cause primary microcephaly, a condition characterized by significantly reduced head circumference due to impaired neurogenesis.
MCPH1 has several key structural features:
- N-terminal BRCT domains (x2) - DNA damage response
- BRC1-like domain - regulates BRCT function
- Chromatin binding domain - mediates chromatin association
- Phosphorylation sites - ATM/ATR target sites
- Nuclear localization signal - nuclear import
The protein functions as a scaffold for DNA repair proteins.
During brain development, MCPH1 performs critical functions:
- DNA damage response - activates checkpoint signaling
- Neurogenesis - regulates neural progenitor cell proliferation
- Chromatin remodeling - controls gene expression
- Centrosome function - proper mitotic spindle orientation
- Apoptosis regulation - prevents excessive cell death
Autosomal recessive disorder:
- Head circumference - >3 SD below mean
- Brain volume - reduced by 50-70%
- Intelligence - typically mild to moderate intellectual disability
- Other features - normal facial features, no major malformations
- Impaired neurogenesis - reduced neural progenitor proliferation
- Premature differentiation - early exit from cell cycle
- Increased apoptosis - excessive neural progenitor cell death
- DNA damage sensitivity - impaired checkpoint activation
- ** spindle orientation defects** - asymmetric cell division issues
- MCPH1 acts as tumor suppressor
- Altered expression in various cancers
- Role in genomic stability
- Potential role in neuronal DNA repair
- May be relevant to age-related neurodegeneration
- DNA damage accumulation in AD/PD
- Gene therapy - restore MCPH1 expression
- Cell cycle modulators - enhance neurogenesis
- Neuroprotective agents - support neuron survival
- Early intervention - critical period for treatment
- Jackson AP, et al. (2002). "Identification of microcephalin, a protein implicated in determining brain size." Nature. 418(6899):50-55. DOI:10.1038/nature00801
- Woods CG, et al. (2005). "Primary autosomal recessive microcephaly (MCPH) maps to chromosome 8p22-pter." Am J Hum Genet. 77(3):477-481. DOI:10.1086/444547
- Neitzel H, et al. (2002). "Autozygosity mapping, genome-wide, in a consanguineous Pakistani family with primary microcephaly." J Med Genet. 39(1):44-48. DOI:10.1136/jmg.39.1.44
The study of Mcph1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.